The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study.

Neuropsychiatr Dis Treat · 2017 · PMC5407443 · PMID 28461752

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

approached significanceP =0.052so close (0.05 < p ≤ 0.1)

Although the differences in mean Week 8 dose of amisulpride between the groups were not statistically significant, the difference between patients who switched from olanzapine and treatment-naïve patients approached significance ( P =0.052).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.